Skip to main content
Log in

Pharmacokinetics of triamterene and its metabolite in man

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The pharmacokinetic profiles of triamterene and hydroxytriamterene sulfuric acid ester, the major metabolite of triamterene, were studied in six normal male volunteers using a newly developed specific HPLC analytical method. Following a 100 mg oral dose of triamterene, the plasma concentration time course of the sulfate conjugate parallels that of triamterene in all subjects, but concentrations of the metabolite were more than 10 times higher than unchanged triamterene concentrations at identical sampling times. Interestingly, the renal clearance of the sulfate conjugate was less than that of triamterene. These characteristic features of triamterene disposition were fitted to a compartment model incorporating a first-pass metabolic process. Unbound fractions of triamterene and metabolite in plasma were 0.39 and 0.10 (mean of 6 subjects), respectively. The low unbound fraction of the metabolite in plasma most probably accounts for the low renal clearance of the sulfate conjugate as compared with triamterene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E. J. Thompson, E. Torres, S. J. Grosberg, and M. M. Maldonado. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.Clin. Pharmacol. Ther. 21:392–394 (1976).

    Google Scholar 

  2. H. Krauf, W. Möhrke, E. Mutschier, and K. D. Völger. Zur Bioverf/:ugbarkeit von Hydrochlorothiazid und Triamteren aus Fertigarzneimitteln.Arzneim. Forsch./ Drug Res. 29:1001–1004 (1980).

    Google Scholar 

  3. K. B. Hansen and A. D. Bender. Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene-hydrochlorothiazide combination.Clin. Pharmacol. Ther. 8:392–399 (1966).

    Google Scholar 

  4. G. H. Mudge. Diuretics and other agents employed in the mobilization of edema. InThe Pharmacological Basis of Therapeutics, 6th ed., A. G. Gilman, L. S. Goodman, and A. Gilman (eds.). Macmillan, New York, 1980, pp. 157–183.

    Google Scholar 

  5. G. Leilich, H. Knauf, E. Mutschler, and K. D. Völger. Influence of triamterene and hydroxytriamterene sulfuric acid ester on diuresis and saluresis in rats after oral and intravenous application.Arzneim. Forsch./ Drug Res. 30:949–953 (1980).

    CAS  Google Scholar 

  6. A. W. Pruitt, J. S. Winkel, and P. G. Dayton. Variations in the fate of triamterene.Clin. Pharmacol. Ther. 21:610–619 (1977).

    CAS  PubMed  Google Scholar 

  7. U. Gundert-Remy, D. Kenne, E. Weber, H. E. Geissler, B. Grebian, and E. Mutschler. Plasma and urinary levels of triamterene and certain metabolites after oral administration to man.Eur. J. Clin. Pharmacol. 16:39–44 (1979).

    Article  CAS  PubMed  Google Scholar 

  8. E. T. Lin, F. Sörgel, J. Hasegawa, and L. Z. Benet. HPLC analysis of triamterene and metabolites in plasma. Abstract, Academy of Pharmaceutical Sciences Meeting, San Antonio, Texas (November 1980).

  9. D. E. Smith, E. T. Lin, and L. Z. Benet. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolic-specific assay.Drug Metab. Dispos. 8:337–342 (1980).

    CAS  PubMed  Google Scholar 

  10. N. H. G. Holford. MKMODEL, inPublic Procedures Notebook, H. M. Perry and J. J. Wood (eds.). Bolt Beranek and Newman, Cambridge, Mass., 1982.

    Google Scholar 

  11. P. A. Castleman, C. H. Russel, F. N. Webb, C. A. Hollister, J. R. Siegel, S. R. Zdonik, and D. M. Fram. The implementation of the PROPHET system,Natl. Comput. Conf. Exposition Proc. 43:457–468 (1974).

    Google Scholar 

  12. G. D. Knott. MLAB—a mathematical modeling tool.Comput. Programs Biomed. 10:271–280 (1979).

    Article  CAS  PubMed  Google Scholar 

  13. A. Akaike. A new look at the statistical model identification.IEEE Trans. Automat. Control 19:716–723 (1973).

    Article  Google Scholar 

  14. K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations.J. Pharmacokinet. Biopharm. 6:165–175 (1978).

    Article  CAS  PubMed  Google Scholar 

  15. H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff. Statistical estimations in pharmacokinetics.J. Pharmacokinet. Biopharm. 2:123–148 (1974).

    Article  CAS  PubMed  Google Scholar 

  16. K. S. Pang and J. R. Gillette. Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.J. Pharmacol Exp. Ther. 207:178–194 (1978).

    CAS  PubMed  Google Scholar 

  17. K. S. Pang and J. R. Gillette. Sequential first-pass elimination of a metabolite derived from a precursor.J. Pharmacokinet. Biopharm. 7:275–290 (1979).

    Article  CAS  PubMed  Google Scholar 

  18. S. Øie and T. N. Tozer. Effect of altered plasma protein binding on apparent volume of distribution.J. Pharm. Sci. 68:1203–1205 (1979).

    Article  PubMed  Google Scholar 

  19. K. M. Kessler, R. C. Leech, and J. F. Spann. Blood collection techniques, heparin and quinidine proten binding.Clin. Pharmacol. Ther. 25:204–210 (1979).

    CAS  PubMed  Google Scholar 

  20. R. H. Cotham and D. Shand. Spuriously low plasma propranolol concentrations resulting from blood collection methods.Clin. Pharmacol. Ther. 18:535–538 (1975).

    CAS  PubMed  Google Scholar 

  21. K. M. Piafsky. Disease-induced changes in the plasma binding of basic drugs.Clin. Pharmacokin. 5:246–262 (1980).

    Article  CAS  Google Scholar 

  22. S. Øie and L. Z. Benet. Altered drug disposition in disease states.Annu. Rep. Med. Chem. 15:277–287 (1980).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by NIH Grant AM20884 and funds from Mylan Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasegawa, J., Lin, E.T., Williams, R.L. et al. Pharmacokinetics of triamterene and its metabolite in man. Journal of Pharmacokinetics and Biopharmaceutics 10, 507–523 (1982). https://doi.org/10.1007/BF01059034

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01059034

Key words

Navigation